dc.creator | Oliveira, Maiara de Souza | |
dc.creator | Santana, Ádila Angélica Dantas de | |
dc.creator | Correa, Rodrigo S | |
dc.creator | Soares, Milena Botelho Pereira | |
dc.creator | Batista, Alzir Azevedo | |
dc.creator | Bezerra, Daniel Pereira | |
dc.date | 2018-06-29T16:37:13Z | |
dc.date | 2018-06-29T16:37:13Z | |
dc.date | 2018 | |
dc.date.accessioned | 2023-09-26T23:12:06Z | |
dc.date.available | 2023-09-26T23:12:06Z | |
dc.identifier | OLIVEIRA, M. S. et al. Ru(II)-Thymine Complex Causes Cell Growth Inhibition and Induction of Caspase-Mediated Apoptosis in Human Promyelocytic Leukemia HL-60 Cells. International Journal of Molecular Sciences, v. 19, p. 1609, 2018. | |
dc.identifier | 1661-6596 | |
dc.identifier | https://www.arca.fiocruz.br/handle/icict/27202 | |
dc.identifier | 10.3390/ijms19061609 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/8887955 | |
dc.description | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP). In particular, R.S.C. would like to thank CNPq for the grants #403588/2016-2 and #308370/2017-1. | |
dc.description | Ruthenium-based compounds represent a class of potential antineoplastic drugs. Recently, we designed, synthesized, and identified the Ru(II)-thymine complex [Ru(PPh₃)₂(Thy)(bipy)]PF₆ (where PPh = triphenylphosphine, Thy = thymine and bipy = 2,2'-bipyridine) as a potent cytotoxic agent with the ability to bind to DNA and human and bovine serum albumins. In this study, the underlying cytotoxic mechanism of the [Ru(PPh₃)₂(Thy)(bipy)]PF₆ complex was assessed. This complex displayed potent cytotoxicity in different cancer cell lines; the morphology that is associated with apoptotic cell death, increased internucleosomal DNA fragmentation without cell membrane permeability, loss of the mitochondrial transmembrane potential, increased phosphatidylserine externalization, and caspase-3 activation were observed in human promyelocytic leukemia HL-60 cells that were treated with the complex. Moreover, pretreatment of HL-60 cells with Z-VAD(OMe)-FMK, a pan-caspase inhibitor, partially reduced the apoptosis that was induced by the complex, indicating that the apoptotic cell death occurred through a caspase-mediated pathway. In conclusion, the [Ru(PPh₃)₂(Thy)(bipy)]PF₆ complex displays potent cytotoxicity to different cancer cells and induces caspase-mediated apoptosis in HL-60 cells. | |
dc.format | application/pdf | |
dc.language | eng | |
dc.publisher | MDPI | |
dc.rights | open access | |
dc.subject | Rutênio | |
dc.subject | Timina | |
dc.subject | Citotoxicidade | |
dc.subject | Apoptose | |
dc.subject | HL-60 | |
dc.subject | Ruthenium | |
dc.subject | Thymine | |
dc.subject | Cytotoxicity | |
dc.subject | Apoptosis | |
dc.subject | HL-60 | |
dc.title | Ru(II)-Thymine Complex Causes Cell Growth Inhibition and Induction of Caspase-Mediated Apoptosis in Human Promyelocytic Leukemia HL-60 Cells | |
dc.type | Article | |